Cargando…
Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
Epitope characterization is critical for elucidating the mechanism of action of drug candidates. However, traditional high-resolution epitope mapping techniques are not well suited for screening numerous drug candidates recognizing a similar target. Here, we use Hydrogen-Deuterium Exchange Mass Spec...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427009/ https://www.ncbi.nlm.nih.gov/pubmed/30894620 http://dx.doi.org/10.1038/s41598-019-41179-0 |
_version_ | 1783405118273617920 |
---|---|
author | Puchades, Cristina Kűkrer, Başak Diefenbach, Otto Sneekes-Vriese, Eveline Juraszek, Jarek Koudstaal, Wouter Apetri, Adrian |
author_facet | Puchades, Cristina Kűkrer, Başak Diefenbach, Otto Sneekes-Vriese, Eveline Juraszek, Jarek Koudstaal, Wouter Apetri, Adrian |
author_sort | Puchades, Cristina |
collection | PubMed |
description | Epitope characterization is critical for elucidating the mechanism of action of drug candidates. However, traditional high-resolution epitope mapping techniques are not well suited for screening numerous drug candidates recognizing a similar target. Here, we use Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to explore the conformational impact of diverse drug molecules binding on Hemagglutinin (HA), the major surface antigen of influenza viruses. We optimized a semi-automated HDX-MS workflow to systematically probe distantly related HA subtypes in complex with 4 different drug candidates, ranging from a monoclonal antibody to a small synthetic peptide. This fast, cost-effective HDX-MS epitope mapping approach accurately determined the main antigenic site in all cases. Moreover, our studies reveal distinct changes in the local conformational dynamics of HA associated to the molecular mechanism of neutralization, establishing a marker for broad anti-HA activity. Taken together, these findings highlight the potential for HDX-MS epitope mapping-based screening to identify promising candidates against HA at early stages of drug discovery. |
format | Online Article Text |
id | pubmed-6427009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64270092019-03-28 Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS Puchades, Cristina Kűkrer, Başak Diefenbach, Otto Sneekes-Vriese, Eveline Juraszek, Jarek Koudstaal, Wouter Apetri, Adrian Sci Rep Article Epitope characterization is critical for elucidating the mechanism of action of drug candidates. However, traditional high-resolution epitope mapping techniques are not well suited for screening numerous drug candidates recognizing a similar target. Here, we use Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to explore the conformational impact of diverse drug molecules binding on Hemagglutinin (HA), the major surface antigen of influenza viruses. We optimized a semi-automated HDX-MS workflow to systematically probe distantly related HA subtypes in complex with 4 different drug candidates, ranging from a monoclonal antibody to a small synthetic peptide. This fast, cost-effective HDX-MS epitope mapping approach accurately determined the main antigenic site in all cases. Moreover, our studies reveal distinct changes in the local conformational dynamics of HA associated to the molecular mechanism of neutralization, establishing a marker for broad anti-HA activity. Taken together, these findings highlight the potential for HDX-MS epitope mapping-based screening to identify promising candidates against HA at early stages of drug discovery. Nature Publishing Group UK 2019-03-18 /pmc/articles/PMC6427009/ /pubmed/30894620 http://dx.doi.org/10.1038/s41598-019-41179-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Puchades, Cristina Kűkrer, Başak Diefenbach, Otto Sneekes-Vriese, Eveline Juraszek, Jarek Koudstaal, Wouter Apetri, Adrian Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS |
title | Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS |
title_full | Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS |
title_fullStr | Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS |
title_full_unstemmed | Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS |
title_short | Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS |
title_sort | epitope mapping of diverse influenza hemagglutinin drug candidates using hdx-ms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427009/ https://www.ncbi.nlm.nih.gov/pubmed/30894620 http://dx.doi.org/10.1038/s41598-019-41179-0 |
work_keys_str_mv | AT puchadescristina epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms AT kukrerbasak epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms AT diefenbachotto epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms AT sneekesvrieseeveline epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms AT juraszekjarek epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms AT koudstaalwouter epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms AT apetriadrian epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms |